REMIBRUTINIB

REMIBRUTINIB was reported 1354 times

REMIBRUTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLEEDING RISK ASSESSMENT 1 1.0000
1 PLATELET DISTRIBUTION WIDTH DECREASED 3 0.0638
2 MENTAL DISORDER DUE TO A GENERAL MEDICAL CONDITION 15 0.0479
3 CHRONIC SPONTANEOUS URTICARIA 44 0.0379
4 PHAGOCYTOSIS 1 0.0312
5 ANTI-THYROID ANTIBODY INCREASED 3 0.0238
6 PETECHIAE 185 0.0177
7 NASAL MUCOSAL EROSION 1 0.0175
8 HYPOAESTHESIA TEETH 2 0.0156
9 EOSINOPHIL PERCENTAGE DECREASED 3 0.0151
10 MUCOCUTANEOUS HAEMORRHAGE 2 0.0134
11 ALICE IN WONDERLAND SYNDROME 1 0.0098
12 INTESTINAL BARRIER DYSFUNCTION 1 0.0086
13 VESSEL PERFORATION 1 0.0076
14 URTICARIA CHRONIC 4 0.0071
15 HEAVY MENSTRUAL BLEEDING 59 0.0066
16 IDIOPATHIC URTICARIA 7 0.0065
17 THROAT CLEARING 23 0.0061
18 SWELLING OF NOSE 1 0.0058
19 INTESTINAL HAEMATOMA 1 0.0057
20 GENITOURINARY SYMPTOM 1 0.0055
21 MALIGNANT MELANOMA STAGE 0 1 0.0048
22 PERIORBITAL HAEMORRHAGE 1 0.0046
23 MAST CELL ACTIVATION SYNDROME 6 0.0043
24 ELECTROCARDIOGRAM ST-T CHANGE 3 0.0042
25 INTRAOCULAR PRESSURE TEST 1 0.0042
26 MOLE EXCISION 1 0.0041
27 BASOPHIL COUNT INCREASED 3 0.0040
28 ECZEMA INFECTED 1 0.0037
29 MEAN PLATELET VOLUME DECREASED 3 0.0036
30 DYSPLASTIC NAEVUS 1 0.0028
31 SHOCK SYMPTOM 1 0.0027
32 NASAL TURBINATE HYPERTROPHY 1 0.0027
33 LARYNGEAL PAIN 1 0.0025
34 POLYCYTHAEMIA VERA 2 0.0024
35 ARTERY DISSECTION 1 0.0024
36 HAEMANGIOMA OF SKIN 1 0.0023
37 TONGUE ERUPTION 1 0.0020
38 CAPILLARY FRAGILITY 1 0.0020
39 BLOOD BLISTER 6 0.0019
40 HYPHAEMA 1 0.0019
41 EPHELIDES 1 0.0019
42 SYMPTOM RECURRENCE 11 0.0018
43 OLIGOMENORRHOEA 4 0.0018
44 HELICOBACTER TEST POSITIVE 1 0.0018
45 NASAL MUCOSAL DISORDER 1 0.0017
46 NEUROPSYCHOLOGICAL SYMPTOMS 1 0.0017
47 URETHRAL HAEMORRHAGE 1 0.0017
48 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS PERFORMED IN ERROR 1 0.0016
49 NEURODEGENERATIVE DISORDER 1 0.0016
50 GINGIVAL BLEEDING 22 0.0016
51 LIP DISCOLOURATION 2 0.0016
52 FACIAL DISCOMFORT 1 0.0014
53 LARYNGEAL DISORDER 1 0.0014
54 CONTUSION 130 0.0013
55 OESOPHAGEAL DISCOMFORT 1 0.0013
56 UTERINE ENLARGEMENT 1 0.0013
57 ENZYME LEVEL INCREASED 1 0.0012
58 LIP PRURITUS 1 0.0012
59 FIXED ERUPTION 2 0.0012
60 GINGIVAL ERYTHEMA 1 0.0012
61 URTICARIA 186 0.0011
62 BONE CONTUSION 1 0.0011
63 TONGUE INJURY 1 0.0011
64 DUODENAL ULCER HAEMORRHAGE 3 0.0010
65 CONJUNCTIVAL HAEMORRHAGE 4 0.0010
66 DISCOLOURED VOMIT 1 0.0010
67 BLOOD URINE 1 0.0010
68 ALCOHOL INTERACTION 2 0.0010
69 PHARYNGEAL SWELLING 10 0.0010
70 ECCHYMOSIS 7 0.0010
71 PURPURA 9 0.0010
72 BLOOD IMMUNOGLOBULIN M DECREASED 1 0.0010
73 EAR HAEMORRHAGE 2 0.0010
74 SKIN SENSITISATION 1 0.0010
75 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
76 PRODUCT NAME CONFUSION 1 0.0009
77 INTERMENSTRUAL BLEEDING 5 0.0009
78 DISCOURAGEMENT 2 0.0009
79 MATERNAL EXPOSURE TIMING UNSPECIFIED 3 0.0008
80 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
81 VASODILATATION 2 0.0008
82 PHARYNGEAL ULCERATION 1 0.0008
83 DISCHARGE 1 0.0007
84 VASCULAR INJURY 1 0.0007
85 PANCREATIC ENZYMES INCREASED 1 0.0007
86 DARK CIRCLES UNDER EYES 1 0.0007
87 ORAL MUCOSAL EXFOLIATION 1 0.0007
88 ANGIOEDEMA 29 0.0007
89 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
90 TYMPANIC MEMBRANE PERFORATION 1 0.0006
91 LOWER RESPIRATORY TRACT CONGESTION 1 0.0006
92 TONGUE COATED 1 0.0006
93 TREATMENT DELAYED 1 0.0006
94 BRONCHIOLITIS 2 0.0006
95 PAPULE 4 0.0006
96 BREAST CYST 1 0.0006
97 HAEMORRHAGIC DIATHESIS 2 0.0006
98 AORTIC VALVE STENOSIS 1 0.0006
99 PRODUCT SUPPLY ISSUE 4 0.0006
100 NASAL OBSTRUCTION 1 0.0005
101 DISSOCIATION 4 0.0005
102 NASAL SEPTUM DEVIATION 1 0.0005
103 CONCOMITANT DISEASE PROGRESSION 1 0.0005
104 BLOOD DISORDER 4 0.0005
105 PARAESTHESIA ORAL 7 0.0005
106 MENSTRUAL DISORDER 4 0.0005
107 LIVEDO RETICULARIS 1 0.0005
108 EYE CONTUSION 1 0.0005
109 VITAMIN D DECREASED 4 0.0005
110 EXOPHTHALMOS 1 0.0005
111 RASH MACULAR 16 0.0005
112 MIDDLE EAR EFFUSION 1 0.0005
113 EYE HAEMORRHAGE 6 0.0004
114 OROPHARYNGEAL DISCOMFORT 4 0.0004
115 HAEMANGIOMA 1 0.0004
116 LICHEN PLANUS 1 0.0004
117 IMPLANT SITE INFECTION 1 0.0004
118 ROSACEA 2 0.0004
119 OXYGEN CONSUMPTION INCREASED 1 0.0004
120 INCORRECT DOSAGE ADMINISTERED 2 0.0004
121 SENSITIVE SKIN 3 0.0004
122 SNEEZING 9 0.0004
123 ABNORMAL UTERINE BLEEDING 1 0.0004
124 PRODUCT TEMPERATURE EXCURSION ISSUE 2 0.0004
125 BLOOD ALBUMIN DECREASED 3 0.0004
126 NASAL DISORDER 1 0.0004
127 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
128 WHITE BLOOD CELL DISORDER 1 0.0004
129 BLOOD URINE PRESENT 7 0.0004
130 HYPOMENORRHOEA 1 0.0004
131 ANAPHYLACTIC REACTION 20 0.0004
132 EOSINOPHILIC OESOPHAGITIS 1 0.0004
133 MACULE 1 0.0004
134 MOUTH SWELLING 2 0.0003
135 NECK INJURY 1 0.0003
136 DYSAESTHESIA 1 0.0003
137 INCREASED TENDENCY TO BRUISE 3 0.0003
138 LARYNGEAL OEDEMA 2 0.0003
139 PIGMENTATION DISORDER 2 0.0003
140 PRODUCT DISTRIBUTION ISSUE 3 0.0003
141 FAECES DISCOLOURED 7 0.0003
142 VAGINAL HAEMORRHAGE 14 0.0003
143 BRAIN FOG 5 0.0003
144 INFUSION SITE HAEMORRHAGE 1 0.0003
145 ULCER HAEMORRHAGE 2 0.0003
146 RASH ERYTHEMATOUS 14 0.0003
147 TREATMENT FAILURE 24 0.0003
148 LYMPHOEDEMA 2 0.0003
149 HYPOPNOEA 1 0.0003
150 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
151 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
152 FEAR OF INJECTION 2 0.0003
153 RHINORRHOEA 18 0.0003
154 PRURITUS 105 0.0003
155 BLOOD CALCIUM DECREASED 3 0.0003
156 BLOOD SODIUM DECREASED 5 0.0003
157 PARANASAL SINUS DISCOMFORT 1 0.0003
158 PRODUCT STORAGE ISSUE 1 0.0003
159 PRODUCT AVAILABILITY ISSUE 6 0.0003
160 HAEMATURIA 9 0.0003
161 OESOPHAGEAL DISORDER 1 0.0003
162 FOOD ALLERGY 2 0.0003
163 THROAT TIGHTNESS 7 0.0003
164 ELECTROLYTE IMBALANCE 3 0.0003
165 PANIC DISORDER 1 0.0003
166 RHINOVIRUS INFECTION 1 0.0003
167 NASAL CONGESTION 15 0.0003
168 SKIN ODOUR ABNORMAL 1 0.0003
169 EPISTAXIS 19 0.0003
170 HAEMATOCHEZIA 14 0.0003
171 SKIN PAPILLOMA 1 0.0002
172 SENSORY LOSS 2 0.0002
173 SKIN BURNING SENSATION 17 0.0002
174 UTERINE HAEMORRHAGE 1 0.0002
175 CHAPPED LIPS 1 0.0002
176 RHINITIS ALLERGIC 1 0.0002
177 THIRST 4 0.0002
178 IRON DEFICIENCY 1 0.0002
179 SINUS CONGESTION 3 0.0002
180 HAEMORRHAGE 23 0.0002
181 EAR DISORDER 1 0.0002
182 HUNGER 3 0.0002
183 SINUS TACHYCARDIA 3 0.0002
184 ENDOMETRIOSIS 1 0.0002
185 DRUG INTOLERANCE 20 0.0002
186 RASH VESICULAR 1 0.0002
187 DIZZINESS POSTURAL 2 0.0002
188 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
189 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
190 SKIN HAEMORRHAGE 3 0.0002
191 VEIN DISORDER 1 0.0002
192 DRY THROAT 2 0.0002
193 INCREASED UPPER AIRWAY SECRETION 1 0.0002
194 ANAPHYLACTIC SHOCK 5 0.0002
195 THERAPY PARTIAL RESPONDER 3 0.0002
196 SWOLLEN TONGUE 6 0.0002
197 SCRATCH 2 0.0002
198 HEREDITARY ANGIOEDEMA 2 0.0002
199 RECTAL HAEMORRHAGE 8 0.0002
200 LIP SWELLING 6 0.0002
201 EYE PRURITUS 6 0.0002
202 THERAPY NON-RESPONDER 8 0.0002
203 PERIORBITAL SWELLING 1 0.0002
204 CONDITION AGGRAVATED 53 0.0002
205 SKIN WARM 1 0.0002
206 DYSPHONIA 10 0.0002
207 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
208 GENERALISED OEDEMA 2 0.0002
209 NASAL DRYNESS 1 0.0002
210 SWELLING OF EYELID 1 0.0002
211 MIGRAINE 15 0.0002
212 HAEMORRHOIDS 3 0.0002
213 AMNESIA 10 0.0002
214 VIRAL INFECTION 5 0.0002
215 SKIN MASS 1 0.0001
216 QUALITY OF LIFE DECREASED 2 0.0001
217 WRONG PRODUCT ADMINISTERED 1 0.0001
218 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
219 NO ADVERSE EVENT 26 0.0001
220 OROPHARYNGEAL PAIN 13 0.0001
221 RETINAL HAEMORRHAGE 1 0.0001
222 TONGUE DISORDER 1 0.0001
223 UTERINE LEIOMYOMA 1 0.0001
224 CEREBRAL DISORDER 1 0.0001
225 GASTROINTESTINAL DISORDER 12 0.0001
226 ECZEMA 7 0.0001
227 GENERAL SYMPTOM 1 0.0001
228 APHTHOUS ULCER 1 0.0001
229 COUGH 36 0.0001
230 DISEASE RECURRENCE 6 0.0001
231 GINGIVAL PAIN 1 0.0001
232 ABDOMINAL PAIN 29 0.0001
233 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
234 MATERNAL EXPOSURE DURING PREGNANCY 11 0.0001
235 HEADACHE 77 0.0001
236 ABNORMAL FAECES 1 0.0001
237 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
238 HAIR DISORDER 1 0.0001
239 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
240 COAGULOPATHY 2 0.0001
241 SWELLING 11 0.0001
242 SKIN HYPERPIGMENTATION 1 0.0001
243 PRODUCT DOSE OMISSION ISSUE 34 0.0001
244 GASTRITIS 3 0.0001
245 IMMUNOSUPPRESSION 1 0.0001
246 RESPIRATORY RATE INCREASED 1 0.0001
247 DRUG INEFFECTIVE 148 0.0001
248 GASTROINTESTINAL INFECTION 1 0.0001
249 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
250 PAIN OF SKIN 3 0.0001
251 HIDRADENITIS 1 0.0001
252 ACCIDENTAL OVERDOSE 4 0.0001
253 CONJUNCTIVITIS 2 0.0001
254 EYE SWELLING 4 0.0001
255 ERYTHEMA 22 0.0001
256 DIARRHOEA HAEMORRHAGIC 1 0.0001
257 ILLNESS 11 0.0001
258 SPUTUM DISCOLOURED 1 0.0001
259 CONFUSIONAL STATE 17 0.0001
260 PRODUCT USE IN UNAPPROVED INDICATION 26 0.0001
261 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
262 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
263 AUTOIMMUNE DISORDER 1 0.0001
264 HYPERSENSITIVITY 19 0.0001
265 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
266 VITREOUS FLOATERS 1 0.0001
267 KNEE OPERATION 1 0.0001
268 ABDOMINAL DISCOMFORT 17 0.0001
269 BLOOD POTASSIUM DECREASED 3 0.0001
270 TOOTH ABSCESS 1 0.0001
271 SUBARACHNOID HAEMORRHAGE 1 0.0001
272 BODY TEMPERATURE INCREASED 2 0.0001
273 UNINTENDED PREGNANCY 1 0.0001
274 RENAL PAIN 1 0.0001
275 PALPITATIONS 11 0.0001
276 LIVER FUNCTION TEST INCREASED 2 0.0001
277 SKIN CANCER 2 0.0001
278 MENSTRUATION DELAYED 1 0.0001
279 SWELLING FACE 6 0.0001
280 SKIN LACERATION 1 0.0001
281 RASH 40 0.0001
282 MELAENA 2 0.0001
283 SKIN INFECTION 1 0.0001
284 OCULAR DISCOMFORT 1 0.0001
285 EYE INFECTION 1 0.0001
286 REBOUND EFFECT 1 0.0001
287 MICTURITION URGENCY 1 0.0001
288 INTERNAL HAEMORRHAGE 1 0.0001
289 NASOPHARYNGITIS 16 0.0001
290 NIGHTMARE 3 0.0001
291 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
292 VASCULITIS 1 0.0001
293 INFLUENZA LIKE ILLNESS 7 0.0001
294 OCULAR HYPERAEMIA 4 0.0001
295 BLOOD IRON DECREASED 1 0.0001
296 ACCIDENT 1 0.0001
297 PANIC ATTACK 3 0.0001
298 SMALL INTESTINAL OBSTRUCTION 1 0.0001
299 SPINAL OPERATION 1 0.0001
300 HAIR COLOUR CHANGES 1 0.0001
301 SECRETION DISCHARGE 1 0.0001
302 PRODUCT COMPLAINT 2 0.0001
303 HAEMATEMESIS 2 0.0001
304 FLUSHING 8 0.0001
305 FLUID RETENTION 4 0.0001
306 INJECTION SITE IRRITATION 1 0.0001
307 THERAPY CESSATION 4 0.0001
308 SKIN ULCER 2 0.0001
309 DERMATITIS ATOPIC 4 0.0001
310 MENSTRUATION IRREGULAR 2 0.0001
311 PRODUCT USE ISSUE 14 0.0001
312 DRY MOUTH 6 0.0001
313 LIMB INJURY 2 0.0001
314 NAUSEA 58 0.0001
315 PERIPHERAL COLDNESS 1 0.0001
316 APPLICATION SITE RASH 1 0.0001
317 ORAL DISCOMFORT 1 0.0001
318 BLISTER 4 0.0001
319 HEART RATE INCREASED 7 0.0001
320 MYALGIA 12 0.0001
321 BRONCHOSPASM 1 0.0001
322 PARALYSIS 1 0.0001
323 HYPOAESTHESIA ORAL 1 0.0001
324 APHASIA 2 0.0001
325 LACRIMATION INCREASED 2 0.0001
326 EPILEPSY 2 0.0001
327 INSURANCE ISSUE 1 0.0001
328 OFF LABEL USE 57 0.0001
329 DEVICE RELATED INFECTION 1 0.0001
330 THYROID DISORDER 1 0.0001
331 LIMB DISCOMFORT 2 0.0001
332 TENDONITIS 1 0.0001
333 RESPIRATORY TRACT CONGESTION 1 0.0001
334 NIGHT SWEATS 2 0.0001
335 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
336 PHOTOSENSITIVITY REACTION 1 0.0001
337 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
338 ANGER 2 0.0001
339 CHEST DISCOMFORT 6 0.0001
340 PERIPHERAL SWELLING 9 0.0001
341 ABDOMINAL PAIN UPPER 12 0.0001
342 INJECTION SITE REACTION 4 0.0001
343 ABDOMINAL DISTENSION 6 0.0001
344 PARAESTHESIA 9 0.0001
345 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
346 HEAD DISCOMFORT 1 0.0001
347 GOUT 1 0.0001
348 GASTROENTERITIS VIRAL 1 0.0001
349 RASH PRURITIC 3 0.0001
350 OSTEOMYELITIS 1 0.0001
351 RESTLESS LEGS SYNDROME 1 0.0001
352 HEPATIC STEATOSIS 1 0.0001
353 OXYGEN SATURATION DECREASED 3 0.0001
354 PHOTOPHOBIA 1 0.0001
355 DYSPNOEA EXERTIONAL 2 0.0001
356 ANXIETY 15 0.0001
357 HERPES ZOSTER 3 0.0001
358 GLAUCOMA 1 0.0001
359 SKIN FISSURES 1 0.0001
360 DYSPEPSIA 5 0.0001
361 DISORIENTATION 2 0.0001
362 FATIGUE 39 0.0001
363 THERAPEUTIC RESPONSE DECREASED 3 0.0000
364 EXTRA DOSE ADMINISTERED 2 0.0000
365 FEEDING DISORDER 1 0.0000
366 POLLAKIURIA 2 0.0000
367 DERMATITIS 1 0.0000
368 MOUTH ULCERATION 1 0.0000
369 SKIN EXFOLIATION 4 0.0000
370 EATING DISORDER 1 0.0000
371 PLATELET COUNT DECREASED 5 0.0000
372 LOSS OF CONSCIOUSNESS 6 0.0000
373 JOINT INJURY 1 0.0000
374 HYPOACUSIS 2 0.0000
375 POOR QUALITY SLEEP 1 0.0000
376 MENTAL DISORDER 2 0.0000
377 DYSPNOEA 26 0.0000
378 PRODUCT PRESCRIBING ISSUE 1 0.0000
379 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
380 RASH MACULO-PAPULAR 1 0.0000
381 ORAL PAIN 1 0.0000
382 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
383 THROAT IRRITATION 2 0.0000
384 ADVERSE DRUG REACTION 4 0.0000
385 CHROMATURIA 1 0.0000
386 HEART RATE IRREGULAR 1 0.0000
387 DRUG INTERACTION 7 0.0000
388 HEPATIC ENZYME INCREASED 3 0.0000
389 NEPHROLITHIASIS 2 0.0000
390 MUSCLE TWITCHING 1 0.0000
391 BURNING SENSATION 3 0.0000
392 THERAPY INTERRUPTED 3 0.0000
393 MENTAL IMPAIRMENT 1 0.0000
394 PRESYNCOPE 1 0.0000
395 ARTHRALGIA 17 0.0000
396 INJECTION SITE SWELLING 3 0.0000
397 HEPATITIS 1 0.0000
398 DIARRHOEA 25 0.0000
399 HAEMATOMA 1 0.0000
400 EXPOSURE VIA SKIN CONTACT 1 0.0000
401 VOMITING 18 0.0000
402 NERVOUSNESS 2 0.0000
403 DIZZINESS 19 0.0000
404 CHEST PAIN 7 0.0000
405 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
406 INJECTION SITE BRUISING 3 0.0000
407 EAR INFECTION 1 0.0000
408 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
409 FEAR 1 0.0000
410 BLOOD BILIRUBIN INCREASED 1 0.0000
411 ANAEMIA 7 0.0000
412 SKIN LESION 1 0.0000
413 MEMORY IMPAIRMENT 5 0.0000
414 ABNORMAL DREAMS 1 0.0000
415 DIVERTICULITIS 1 0.0000
416 MENTAL STATUS CHANGES 1 0.0000
417 FEELING COLD 1 0.0000
418 INFLUENZA 4 0.0000
419 DEMENTIA 1 0.0000
420 ALOPECIA 7 0.0000
421 PAIN IN JAW 1 0.0000
422 INTENTIONAL DOSE OMISSION 1 0.0000
423 RED BLOOD CELL COUNT DECREASED 1 0.0000
424 PANCREATIC CARCINOMA 1 0.0000
425 INFECTION 5 0.0000
426 PAIN 21 0.0000
427 BONE PAIN 2 0.0000
428 INSOMNIA 9 0.0000
429 TACHYCARDIA 3 0.0000
430 RESPIRATORY DISORDER 1 0.0000
431 JOINT SWELLING 4 0.0000
432 STOMATITIS 2 0.0000
433 ILL-DEFINED DISORDER 2 0.0000
434 VERTIGO 2 0.0000
435 DISCOMFORT 2 0.0000
436 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
437 DYSPHAGIA 3 0.0000
438 MOOD SWINGS 1 0.0000
439 URINARY RETENTION 1 0.0000
440 GAIT INABILITY 1 0.0000
441 TYPE 2 DIABETES MELLITUS 1 0.0000
442 COVID-19 5 0.0000
443 HEART RATE DECREASED 1 0.0000
444 SLEEP DISORDER 2 0.0000
445 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
446 C-REACTIVE PROTEIN INCREASED 1 0.0000
447 RESTLESSNESS 1 0.0000
448 INJECTION SITE MASS 1 0.0000
449 DYSARTHRIA 1 0.0000
450 ASTHMA 3 0.0000
451 COLITIS 1 0.0000
452 ACNE 2 0.0000
453 CHILLS 3 0.0000
454 SOMNOLENCE 5 0.0000
455 ASTHENIA 9 0.0000
456 ROAD TRAFFIC ACCIDENT 1 0.0000
457 WITHDRAWAL SYNDROME 1 0.0000
458 PRODUCT STORAGE ERROR 2 0.0000
459 INJECTION SITE PAIN 7 0.0000
460 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
461 INCORRECT DOSE ADMINISTERED 5 0.0000
462 PNEUMONIA 7 0.0000
463 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
464 CARDIAC DISORDER 2 0.0000
465 FEELING ABNORMAL 5 0.0000
466 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
467 ATRIAL FIBRILLATION 2 0.0000
468 DRY EYE 1 0.0000
469 SYNCOPE 2 0.0000
470 BLOOD PRESSURE INCREASED 3 0.0000
471 HYPERTENSION 4 0.0000
472 OEDEMA 1 0.0000
473 NECK PAIN 1 0.0000
474 EYE PAIN 1 0.0000
475 CEREBROVASCULAR ACCIDENT 3 0.0000
476 FLATULENCE 1 0.0000
477 URINARY TRACT INFECTION 3 0.0000
478 PYREXIA 6 0.0000
479 SURGERY 1 0.0000
480 PAIN IN EXTREMITY 5 0.0000
481 WHEEZING 1 0.0000
482 IRRITABILITY 1 0.0000
483 EMOTIONAL DISTRESS 2 0.0000
484 OEDEMA PERIPHERAL 2 0.0000
485 VISUAL IMPAIRMENT 2 0.0000
486 BLOOD PRESSURE DECREASED 1 0.0000
487 DRY SKIN 2 0.0000
488 NEOPLASM MALIGNANT 1 0.0000
489 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
490 MOBILITY DECREASED 1 0.0000
491 AGITATION 1 0.0000
492 BRONCHITIS 1 0.0000
493 DYSGEUSIA 1 0.0000
494 WEIGHT INCREASED 3 0.0000
495 HYPOAESTHESIA 2 0.0000
496 HOT FLUSH 1 0.0000
497 UNEVALUABLE EVENT 1 0.0000
498 BACK PAIN 3 0.0000
499 ARTHRITIS 1 0.0000
500 INJECTION SITE HAEMORRHAGE 1 0.0000
501 THROMBOSIS 1 0.0000
502 BALANCE DISORDER 1 0.0000
503 MYOCARDIAL INFARCTION 2 0.0000
504 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
505 MUSCULOSKELETAL STIFFNESS 1 0.0000
506 MALAISE 5 0.0000
507 MUSCLE SPASMS 2 0.0000
508 WEIGHT DECREASED 3 0.0000
509 BREAST CANCER 1 0.0000
510 NEUROPATHY PERIPHERAL 1 0.0000
511 GAIT DISTURBANCE 2 0.0000
512 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
513 SINUSITIS 1 0.0000
514 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
515 CONSTIPATION 2 0.0000
516 RHEUMATOID ARTHRITIS 1 0.0000
517 DEPRESSION 2 0.0000
518 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
519 DISEASE PROGRESSION 1 0.0000
520 INJECTION SITE ERYTHEMA 1 0.0000
521 HYPERHIDROSIS 1 0.0000
522 DEHYDRATION 1 0.0000
523 VISION BLURRED 1 0.0000
524 TREMOR 1 0.0000
525 FALL 2 0.0000
526 DECREASED APPETITE 1 0.0000